
NASDAQ:SBRA
This summary was created by AI, based on 1 opinions in the last 12 months.
Sabra Health Care REIT (SBRA) stands out as a compelling investment opportunity in 2026, highlighted by experts as a top pick. The company operates primarily in the nursing and behavioral health sectors, which are benefiting from favorable demographic trends. Currently trading at a price-to-FFO ratio of 12x, which is significantly lower than the market average, it offers an attractive 6.5% dividend yield. With an projected earnings growth of 5.5% this year, Sabra has shown impressive momentum, reflected in a 17% increase in share price over the last year. Analysts believe that unlike many sectors threatened by advancements in AI, Sabra could potentially benefit from these technological changes, solidifying its position in the market.
Sabra Health Care REIT is a American stock, trading under the symbol SBRA (previously SBRA-Q on Stockchase) on the NASDAQ (SBRA). It is usually referred to as NASDAQ:SBRA or SBRA
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SBRA (previously SBRA-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is STRONG BUY. Read the latest stock experts' ratings for Sabra Health Care REIT.
Sabra Health Care REIT was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sabra Health Care REIT.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Sabra Health Care REIT.
Sabra Health Care REIT is followed by 6 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-02, Sabra Health Care REIT (SBRA) stock closed at a price of $20.86.
Her top pick of 2026. Trades at 12x FFO, half the market's, and pays a 6.5% dividend. They are in the nursing space (retirement and skilled), and behavioural health. Enjoys demographic winds. Earnings to grow 5.5% this year. Up 17% last year, so has momentum as well as fundamentals. Is not threatened by AI, and could even benefit Sabra.